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OBJECTIVE: To give a cross-sectional overview of ongoing management of
behavioral disorders following traumatic brain injury (TBI) in a region of France, to
compare this with recent recommendations from the French Society of Physical
Medicine and Rehabilitation (SOFMER), and to evaluate associations between
treatments and participant characteristics.
SETTING: Outpatients referred to medical or community-based facilities in a region
of France.
PARTICIPANTS: One hundred twenty-nine adults with moderate to severe TBI, in the
postacute period (over 3 months postinjury).
DESIGN: Cross-sectional cohort study.
MAIN MEASURES: Sociodemographic data, ongoing interventions including
psychotherapy and medication, behavioral disorders assessed by the Behavioral
Dysexecutive Syndrome Inventory (BDSI).
RESULTS: Thirty-three percent of participants received ongoing psychotherapy and
43% were on medication. The most prescribed medications were antidepressants
(21%), neuroleptics (18%), anxiolytics (16%), and mood stabilizers (14%). Eighty-five
participants (71%) presented a current Behavioral Dysexecutive Syndrome (BDS)
according to the BDSI. These participants more frequently received treatment (P =
.004), psychotherapy (P = .048), medications (often 2 or more) (P = .007), and
particularly antiepileptic mood stabilizers (P = .037) compared with those without
BDS.
CONCLUSION: Although recommended as first-line treatment, few participants with
BDS received psychotherapy. Medications were overused, especially neuroleptics in
view of their potential adverse effects. In contrast, recommended medications, such
as mood stabilizers and β-blockers, did not appear to be highly prescribed whatever
the evolution. Compliance with recommendations seemed insufficient.
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